Parathyroid adenoma
ICD-10 D35.1 · ICD-11 2F37.Y.3

What Is the Treatment for Parathyroid Adenoma?

Parathyroid adenoma is a surgically correctable condition. The evidence-based protocol applies to patients who appear, on clinical and imaging assessment, to have a single parathyroid adenoma and are candidates for a focused operative approach.

The protocol centres on a focused, image-guided minimally invasive surgical technique that includes a specific intraoperative confirmation step to verify adequacy of resection before the procedure is concluded.

The protocol targets reestablishment of normal calcium homeostasis (eucalcemia) lasting a minimum of 6 months, and normalization of parathyroid hormone levels assessed at 6 months post-procedure.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1001/jamasurg.2016.2310

Parathyroidectomy is the only definitive treatment of pHPT.

Defined as a focused dissection, MIP is ideally used in patients who appear clinically and by imaging to have a single parathyroid adenoma.

When image-guided focused parathyroidectomy is planned, IPM is suggested to avoid higher operative failure rates.

Minimally invasive parathyroidectomy can achieve cure in 97% to 99% of selected patients when adjunctive IPM is used to confirm adequacy of resection.

Cure after parathyroidectomy is defined as the reestablishment of normal calcium homeostasis lasting a minimum of 6 months.

Although there is no role for routine PTH measurement in the normocalcemic patient in the immediate postoperative period, failure to normalize PTH levels at 6 months or longer can signify early operative failure.

View source ↗